-
Raymond James Downgrades Profound Medical Corp. (PROF) to Outperform, 'we don’t expect big things from PROF’s early ramp in 1H25'
-
Profound Medical Corp. (PROF) Tops Q1 EPS by 65c
-
Profound Medical Stock Alert: Company Reports Error which Overstated Revenue - Kehoe Law Firm, P.C. Investigating - PROF
-
Stifel Reiterates Buy Rating on Profound Medical Corp. (PROF)
-
Profound Medical Corp. (PROF) Tops Q4 EPS by 55c
-
Lake Street Capital Markets Reiterates Buy Rating on Profound Medical Corp. (PROF)
-
Profound Medical Corp. (PROF) Prices 4.67M Share Offering at $7.50/sh
-
Profound Medical Corp. (PROF) PT Raised to $17 at Lake Street Capital Markets
-
Lake Street Capital Markets Starts Profound Medical Corp. (PROF) at Buy
-
Stifel Upgrades Profound Medical Corp. (PROF) to Buy

